Nasdaq stss.
On Invalid Date, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings per share (EPS) of -$0.22, up 466.67% year over year. Total Sharps Technology earnings for the quarter were -$2.61 million. In the same quarter last year, Sharps Technology's earnings per share (EPS) was $0.06.
Apr 19, 2022 · NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a ~$16 Million Initial Public Offering for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps ... NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory. GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine …NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...
STSS Edit my quotes Sharps Technology Inc. Common Stock (STSS) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market Charts STSS STSS …NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...Robert Hayes, CEO of Sharps Technology, Inc. (NASDAQ: STSS), delves into what Sharps does, what exciting developments have transpired such as their major dis...
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...
In connection with the offering, the Company will issue 2,248,521 units and pre-funded units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules.(STSS) raised $16 million in an initial public offering on Thursday, April 14th 2022. The company issued 3,750,000 shares at a price of $4.25 per share. Who are Sharps Technology's major shareholders?RedChip Companies, a renowned international investor relations firm specializing in microcap and small-cap companies,announce the launch of its much-anticipated podcast series, "Small Stocks, Big ...Nov 16, 2023 · Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ... The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...
Feb 1, 2023 · STSS Sharps Technology Inc Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the 'Company', 'Sharps') (NASDAQ: 'STSS' and 'STSSW'), an innovative medical device and drug delivery Company offering patented, ...
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ...The latest price target for Sharps Technology ( NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023. The analyst firm set a price target for 16.00 expecting STSS to rise to within ... NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...The latest price target for . Sharps Technology (NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023.The analyst firm set a price target for 16.00 expecting STSS to rise to within ...Nov 30, 2023 · Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules. NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, ...
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Sharp Technology (NASDAQ:STSS) soared 13% on Tuesday as the medical device company announced a deal to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility.NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class ...Find the latest Financials data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, is pleased to announce the Company completed its acquisition of Safegard Medical’s syringe …
STSS Sharps Technology Inc. 0.80-0.0099 (-1.22%) After Hours. Last Updated: 17:40:18. Delayed by 15 minutes ...
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond. Company to launch next generation specialty polymer-based syringe products for the healthcare marketNov 28, 2023 · Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe ... NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...The common stock and warrants began trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Aegis Capital Corp. acted as the sole book ...Massimo Di posted on LinkedInNEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an ...Find the latest SEC Filings data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. Our common stock and warrants are listed on the Nasdaq Capital Market, or Nasdaq, under the symbols “STSS” and “STSSW”, respectively. On August 28, 2023, the last reported sale price of ...
STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
STSS Stock Overview Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe …
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new partnership focused on developing and sharing best practices in innovative manufacturing, product development, customer support, and quality as ...NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, is pleased to announce the Company completed its acquisition of Safegard Medical’s syringe …Stock Screener Earnings Calendar Sectors Nasdaq | STSS U.S.: Nasdaq Sharps Technology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 26, 2023 6:44 p.m. EDT Delayed... NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company ...Investor Relations. Sharps Technology (Nasdaq: STSS) seeks to enhance shareholder value not only through exceptional business performance and practices, but ...Find the latest Revenue & EPS data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.4,365.98 Home STSS • NASDAQ Sharps Technology Inc Follow Share $0.44 Nov 6, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Innovative Eyewear Inc $0.44 LUCY3.33% Bruush Oral... Feb 6, 2023 · NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...
Find the latest analyst research for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of SalesOn Invalid Date, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings per share (EPS) of -$0.22, up 466.67% year over year. Total Sharps Technology earnings for the quarter were -$2.61 million. In the same quarter last year, Sharps Technology's earnings per share (EPS) was $0.06.Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ...Instagram:https://instagram. xspace stocklithum etfmkdvxiwv stock Aug 1, 2023 · STSS Sharps Technology Inc Form 8-K - Current report. 0001737995 false 0001737995 2023-07-27 2023-07-27 0001737995 STSS:CommonStock0.0001P... Monitor; Quote; Level 2; Movers ... In connection with the offering, the Company will issue 2,248,521 units and pre-funded units at a purchase price of $1.69 per unit priced at-the-market under Nasdaq rules. nyse trading hourscummins hydrogenics Sep 29, 2023 · STSS Sharps Technology Inc Form 8-K - Current report. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of ... An exhaustive system for trade monitoring and crime detection. Nasdaq Trade Surveillance helps you prioritize and focus on urgent alerts by increasing efficiency of data sorting, detection, and ... what is the value of one gold bar Sharps Technology Earnings & Revenue FAQ. What were STSS's earnings last quarter? On Aug 30, 2023, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings ...Is Sharps Technology (NASDAQ:STSS) the best stock in the Surgical & medical instruments industry? Compare top STSS competitors at MarketBeat.